Medical device development and commercialization
3 European H2020 organizations list this as part of their work — 1 as their primary capability.
Most active in this area
- GLYCARDIAL DIAGNOSTICS, SL
Barcelona MedTech SME developing glycan-based in vitro diagnostic device for early cardiac ischemia detection.
“The AGLYC Phase 2 project (2019–2022, €1.9M) under SME-2 funding indicates a full product development and market entry stage, not just research.”
SMEES2 projects - ANNAIDA TECHNOLOGIES SA
Swiss medtech SME developing NMR-based quantitative embryo assessment systems to improve IVF success rates.
“The SME-2 Embryospin project (EUR 1.6M, 2021-2023) signals a transition from proof-of-concept to full-scale product development and market entry preparation.”
SMECH2 projects - KUARTISMED MEDIKAL ARASTIRMA GELISTIRME DANISMANLIK EGITIM SANAYI VE TICARET LIMITED SIRKETI
Turkish medical SME developing a clinical system to assess feeding readiness in premature infants, validated through EU SME Instrument Phase 1 and Phase 2.
“PREMADES Phase 2 (SME-2 scheme, €1.456M) is a commercialization-stage grant, indicating the organization has moved beyond research into product development.”
PrimarySMETR2 projects